Arie Belldegrun - Mar 22, 2023 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role: Director
Signature: /s/Veer Bhavnagri, Attorney-in-Fact
Stock symbol: ALLO
Transactions as of: Mar 22, 2023
Transactions value $: $0
Form type: 4
Date filed: 3/24/2023, 08:14 PM
Previous filing: Sep 16, 2022
Next filing: Jun 21, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALLO	Common Stock	Award	$0	+1.28M	+344.97%	$0.00	1.65M	Mar 22, 2023	Direct	F1
holding	ALLO	Common Stock						195K	Mar 22, 2023	See footnote	F2
holding	ALLO	Common Stock						1.8M	Mar 22, 2023	See footnote	F3
holding	ALLO	Common Stock						4.71M	Mar 22, 2023	See footnote	F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALLO	Stock Option (Right to Buy)	Award	$0	+995K		$0.00	995K	Mar 22, 2023	Common Stock	995K	$5.04	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 986,905 of performance RSUs which shall vest as follows: (1) 50% shall vest if the 30-day weighted average stock price is equal to or greater than $18 and (2) 50% shall vest upon the first regulatory approval of a product candidate. Notwithstanding the foregoing (1) any portion that vests upon the stock price threshold shall no longer vest and be terminated after three years from the grant date if such threshold has not been met in such three-year period, and (2) any portion that vests upon product candidate approval shall no longer vest and be terminated after five years from the grant date if such approval has not occurred in such five-year period.
F2	The securities are held in the name of Bellco Legacy LLC. Bellco Legacy LLC is owned and managed by trusts controlled by the reporting person and Rebecka Belldegrun
F3	The securities are held by Vida Ventures LLC (Vida), of which VV Manager LLC is the manager. The reporting person is a Senior Managing Director of VV Manager LLC and may therefore be deemed to be the beneficial owner of the common shares held by Vida. The reporting person disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.
F4	The securities are held in the name of Bellco Legacy Trust fbo Rebecka Belldegrun, of which the reporting person's spouse is trustee and beneficiary
F5	25% of the shares subject to the stock option shall vest on March 13, 2024, and the remaining shares shall vest in 36 equal monthly installments thereafter.